Skip to main content
. Author manuscript; available in PMC: 2023 Jan 15.
Published in final edited form as: Environ Int. 2021 Dec 15;159:107045. doi: 10.1016/j.envint.2021.107045

Figure 5.

Figure 5.

Pharmacokinetic constants Cmax and AUC0–48hr for [14C]-BaP in plasma as a percentage of Cmax and AUC0–48hr for total [14C] (BaP plus metabolites) as a function of dose. The percent of [14C]-BaP in plasma decreased with increasing dose for both Cmax (r2=0.950, p=0.025) and AUC0–48hr (r2=0.691, p=0.169) although the latter was not significant.